2010 Fiscal Year Final Research Report
Identification of microRNA which is related to chemoresistance of pancreatic cancer, and intensification of the sensitivity by controlling the microRNA.
Project/Area Number |
20591629
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Kyushu University |
Principal Investigator |
TOMA Hiroki Kyushu University, 大学病院, 助教 (80437780)
|
Co-Investigator(Kenkyū-buntansha) |
MIZUMOTO Kazuhiro 九州大学, 大学病院, 准教授 (90253418)
OHUCHIDA Kenoki 九州大学, 医学研究院, 客員助教
|
Project Period (FY) |
2008 – 2010
|
Keywords | 膵臓外科学 / 膵癌 / microRNA / 治療抵抗性 |
Research Abstract |
We established two Gemcitabine-resistant pancreatic cancer cell lines, and global miRNA expression analyses was performed.24 miRNA were candidates that were related to chemoresistance of pancreatic cancer. MiR142-5p and miR204 show most highest expression in two Gemcitabine-resistant pancreatic cancer cell lines. MiR17-5p, miR200c and miR203 were poor prognosis factors. MiR21 and miR155 in pancreatic juice have the potential of becoming new biomarkers for diagnosing pancreatic cancer. MiR21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
|
-
-
-
-
-
[Journal Article] MicroRNA2010
Author(s)
Yu J., et al.
-
Journal Title
hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation Mol Cancer. 28;9
Pages: 169
-
-
-
-
-
[Remarks] ホームページ等 なし